Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats

Atsumi Nitta, Katsuhito Murase, Yoshiko Furukawa, Kyozo Hayashi, Takaaki Hasegawa, Toshitaka Nabeshima

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Nerve growth factor plays an important role in the survival and maintenance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by the loss of neurons in the magnocellular cholinergic neuronal system. It is, therefore, of interest to investigate the role of nerve growth factor in senile dementia of the Alzheimer type. We now found that 6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone (TMQ) stimulates nerve growth factor synthesis in mouse astroglial cells and that the compound has improving effects on memory and choline acetyltransferase activity in basal forebrain-lesioned rats, an amnesia animal model. TMQ ameliorated amnesia in the water maze and passive avoidance tasks. The compound not only restored the reduced choline acetyltransferase activity in the parietal cerebral cortex, but also increased nerve growth factor content and choline acetyltransferase activity in the hippocampus, although it did not change either of these parameters in any brain region in intact rats. These results suggest that the compound activates cholinergic neurons only in the damaged brain and, further, indicate that nerve growth factor stimulators could be used in clinical trials for the treatment of senile dementia of the Alzheimer type.

Original languageEnglish
Pages (from-to)23-30
Number of pages8
JournalEuropean Journal of Pharmacology
Volume250
Issue number1
DOIs
Publication statusPublished - 30-11-1993
Externally publishedYes

Fingerprint

Nerve Growth Factor
Oral Administration
Choline O-Acetyltransferase
Alzheimer Disease
Cholinergic Neurons
Amnesia
Parietal Lobe
Memory Disorders
Brain
Cerebral Cortex
Cholinergic Agents
Hippocampus
Animal Models
Maintenance
Basal Forebrain
Clinical Trials
Learning
Neurons
Water

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Nitta, Atsumi ; Murase, Katsuhito ; Furukawa, Yoshiko ; Hayashi, Kyozo ; Hasegawa, Takaaki ; Nabeshima, Toshitaka. / Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. In: European Journal of Pharmacology. 1993 ; Vol. 250, No. 1. pp. 23-30.
@article{9b178d0907354d34b6ce91cc307888a1,
title = "Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats",
abstract = "Nerve growth factor plays an important role in the survival and maintenance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by the loss of neurons in the magnocellular cholinergic neuronal system. It is, therefore, of interest to investigate the role of nerve growth factor in senile dementia of the Alzheimer type. We now found that 6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone (TMQ) stimulates nerve growth factor synthesis in mouse astroglial cells and that the compound has improving effects on memory and choline acetyltransferase activity in basal forebrain-lesioned rats, an amnesia animal model. TMQ ameliorated amnesia in the water maze and passive avoidance tasks. The compound not only restored the reduced choline acetyltransferase activity in the parietal cerebral cortex, but also increased nerve growth factor content and choline acetyltransferase activity in the hippocampus, although it did not change either of these parameters in any brain region in intact rats. These results suggest that the compound activates cholinergic neurons only in the damaged brain and, further, indicate that nerve growth factor stimulators could be used in clinical trials for the treatment of senile dementia of the Alzheimer type.",
author = "Atsumi Nitta and Katsuhito Murase and Yoshiko Furukawa and Kyozo Hayashi and Takaaki Hasegawa and Toshitaka Nabeshima",
year = "1993",
month = "11",
day = "30",
doi = "10.1016/0014-2999(93)90616-P",
language = "English",
volume = "250",
pages = "23--30",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. / Nitta, Atsumi; Murase, Katsuhito; Furukawa, Yoshiko; Hayashi, Kyozo; Hasegawa, Takaaki; Nabeshima, Toshitaka.

In: European Journal of Pharmacology, Vol. 250, No. 1, 30.11.1993, p. 23-30.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats

AU - Nitta, Atsumi

AU - Murase, Katsuhito

AU - Furukawa, Yoshiko

AU - Hayashi, Kyozo

AU - Hasegawa, Takaaki

AU - Nabeshima, Toshitaka

PY - 1993/11/30

Y1 - 1993/11/30

N2 - Nerve growth factor plays an important role in the survival and maintenance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by the loss of neurons in the magnocellular cholinergic neuronal system. It is, therefore, of interest to investigate the role of nerve growth factor in senile dementia of the Alzheimer type. We now found that 6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone (TMQ) stimulates nerve growth factor synthesis in mouse astroglial cells and that the compound has improving effects on memory and choline acetyltransferase activity in basal forebrain-lesioned rats, an amnesia animal model. TMQ ameliorated amnesia in the water maze and passive avoidance tasks. The compound not only restored the reduced choline acetyltransferase activity in the parietal cerebral cortex, but also increased nerve growth factor content and choline acetyltransferase activity in the hippocampus, although it did not change either of these parameters in any brain region in intact rats. These results suggest that the compound activates cholinergic neurons only in the damaged brain and, further, indicate that nerve growth factor stimulators could be used in clinical trials for the treatment of senile dementia of the Alzheimer type.

AB - Nerve growth factor plays an important role in the survival and maintenance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by the loss of neurons in the magnocellular cholinergic neuronal system. It is, therefore, of interest to investigate the role of nerve growth factor in senile dementia of the Alzheimer type. We now found that 6-(4-hydroxybutyl)-2,3,5-trimethyl-1,4-benzoquinone (TMQ) stimulates nerve growth factor synthesis in mouse astroglial cells and that the compound has improving effects on memory and choline acetyltransferase activity in basal forebrain-lesioned rats, an amnesia animal model. TMQ ameliorated amnesia in the water maze and passive avoidance tasks. The compound not only restored the reduced choline acetyltransferase activity in the parietal cerebral cortex, but also increased nerve growth factor content and choline acetyltransferase activity in the hippocampus, although it did not change either of these parameters in any brain region in intact rats. These results suggest that the compound activates cholinergic neurons only in the damaged brain and, further, indicate that nerve growth factor stimulators could be used in clinical trials for the treatment of senile dementia of the Alzheimer type.

UR - http://www.scopus.com/inward/record.url?scp=0027332575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027332575&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(93)90616-P

DO - 10.1016/0014-2999(93)90616-P

M3 - Article

VL - 250

SP - 23

EP - 30

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -